Two Sigma Investments
LEGN icon

Two Sigma Investments’s Legend Biotech LEGN Stock Holding History

Two Sigma Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Sell
163,903
-1,726,493
-91% -$46.6M ﹤0.01% 2198
2026
Q1 		$34.2M Buy
1,890,396
+1,364,326
+259% +$26M 0.03% 666
2025
Q4 		$11.4M Buy
526,070
+166,135
+46% +$4.76M 0.02% 1032
2025
Q3 		$11.7M Buy
359,935
+90,234
+33% +$3.33M 0.02% 872
2025
Q2 		$9.57M Sell
269,701
-532,080
-66% -$17.2M 0.02% 848
2025
Q1 		$27.2M Buy
801,781
+159,329
+25% +$5.71M 0.06% 388
2024
Q4 		$20.9M Buy
642,452
+581,952
+962% +$24.1M 0.05% 460
2024
Q3 		$2.95M Buy
+60,500
New +$3.22M 0.01% 1412
2023
Q4 		– Sell
-197,219
Closed -$13.2M – 3270
2023
Q3 		$13.2M Buy
197,219
+80,996
+70% +$5.63M 0.04% 506
2023
Q2 		$8.02M Buy
+116,223
New +$7.59M 0.02% 729
2022
Q2 		– Sell
-183,862
Closed -$6.68M – 2751
2022
Q1 		$6.68M Buy
183,862
+144,890
+372% +$5.72M 0.02% 796
2021
Q4 		$1.82M Buy
+38,972
New +$1.98M ﹤0.01% 2006
2021
Q3 		– Sell
-141,689
Closed -$5.82M – 4497
2021
Q2 		$5.82M Buy
+141,689
New +$4.82M 0.01% 1110

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Two Sigma Investments's LEGN Position: Q2 2026 in Review

Two Sigma Investments reduced its Legend Biotech (LEGN) stake by 91% in Q2 2026, selling an estimated $46.6M and leaving 163,903 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Two Sigma Investments first reported a position in LEGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $34.2M in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Two Sigma Investments held 163,903 shares of Legend Biotech worth $4.73M as of Q2 2026.
  • Two Sigma Investments sold 1,726,493 Legend Biotech shares in Q2 2026, an estimated $46.6M.
  • Legend Biotech made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #2198 holding.
  • Two Sigma Investments first reported a position in Legend Biotech in Q2 2021 and has held it in 13 quarters since.
  • Two Sigma Investments's Legend Biotech position peaked at $34.2M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.